Analysts’ Viewpoint on Physician Dispensed Cosmeceuticals Market Scenario
The physician dispensed cosmeceuticals market is likely to witness steady expansion driven by the increase in demand for products and better resolution of supply chain issues in various countries amid the COVID-19 outbreak. Brands in the physician dispensed cosmeceuticals market are under scrutiny for possible side effects and adverse events through the usage of products. Hence, brands should increase awareness about the doctor and physician’s consultation through advertising & marketing for physician dispensed cosmeceutical products. Companies are striving to innovate in dermatologically-approved skincare cosmeceuticals to meet the demand for aging population. Women’s education and penetration of smartphones in rural and remote regions of Asia Pacific such as in India, Sri Lanka, and Bangladesh is helping for increased product uptake.
The growing awareness about facial beauty enhancement is contributing to the expansion of the physician dispensed cosmeceuticals market. An Increasing number of smartphone users are consuming social media to gain awareness about new brands in the physician dispensed cosmeceuticals market. The burgeoning growth of the online influencer community on social media is emerging as an important strategy for brand building.
Apart from branding, communication about natural ingredients in physician dispensed cosmeceuticals is helping to boost product uptake. Such trends are contributing to the expansion of the global physician dispensed cosmeceuticals market. Recycled bottles and cruelty-free products are being preferred by customers.
Burgeoning growth of the eCommerce industry and growing adoption of online shopping apps have made it easier for customers to order products by sitting in the convenience of their homes during the COVID-19 outbreak. Such findings are triggering the expansion of the physician dispensed cosmeceuticals market. However, brands need to address poor market sentiments, since the demand for cosmeceuticals is surging slowly owing to slow movements of goods. Nevertheless, brands and manufacturing are rethinking their supply networks to avoid disruptions in product deliveries.
Import and export of physician dispensed cosmeceuticals are projected to rise due to increase in shipment and demand for products.
Although social media and eCommerce are playing an instrumental role in brand building, negative reviews and low ratings for products tend to affect sales of physician dispensed cosmeceuticals. In a quest to establish transparency and authenticity for facial and skincarecosmeceuticals, brands tend to lose credibility due to unhappy or unsatisfied customers. Hence, brands are developing websites and online portals where they can regulate the comments or reviews posted by consumers.
Brands on popular eCommerce platforms are operating with the mindset of high risk-high reward to make their products available in the public eye. They are developing mobile apps to meet personalized needs of customers and enable repeat purchase of facial and skincare cosmeceuticals. Brands are working closely with physicians to develop mobile apps that offer a personalized experience to customers.
Companies in the physician dispensed cosmeceuticals market are increasing the availability of products that offer both cosmetic and therapeutic benefits to consumers. Increase in consciousness and concerns about stressful lifestyle, aging, and harmful effects of pollution & damage to skin & face due to UV rays are key indicators that are projected to drive the expansion of the global physician dispensed cosmeceuticals market throughout the assessment tenure.
In addition, rising awareness about personal maintenance among the geriatric population and changing attitudes of middle aged population in developing countries are propelling the demand for cosmeceuticals for eliminating the outward aging signs. Women's education in remote and rural regions of Asia Pacific has improved access to advertisements, smartphones, newspapers, and magazines that tend to impart preliminary knowledge to judge genuine and efficacious cosmeceuticals.
The high prevalence of acne, scars, and pigmentation among men and women is translating into value-grab opportunities for participants in the market. There is a growing demand for scar-reducing cosmeceuticals that enable skin lightening, rhytide reduction, and anti aging. Increase in usage of physician prescribed scar reduction products to clean and treat various scars is contributing toward market expansion.
The demand for physician dispensed face-care products has increased, since most of the people are seeking physician’s or doctor’s consultation to treat various facial conditions in order to reduce the use of chemicals ingredients that can aggravate the facial conditions.
|
Attribute |
Detail |
|
Market Size Value in 2020 |
US$ 8.5 Bn |
|
Market Forecast Value in 2031 |
US$ 19 Bn |
|
Growth Rate (CAGR) |
7.8% |
|
Forecast Period |
2021–2031 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Physician dispensed cosmeceuticals market is expected to reach the value of US$ 19 Bn by the end of 2031
Physician dispensed cosmeceuticals market is estimated to expand at a CAGR of 7.8% from 2021 to 2031
Physician dispensed cosmeceuticals market is driven by increase in awareness about cosmeceuticals among most of the upper- and middle-class women and men in developed countries
North America accounted for a major share of the global physician dispensed cosmeceuticals market
Key players in the global physician dispensed cosmeceuticals market include AbbVie, Inc. (Allergan), L'Oreal S.A., Jan Marini Skin Research, Inc., Athena Cosmetics, Inc., ZO Skin Health, Inc
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Physician Dispensed Cosmeceuticals Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Product/ Brand Analysis
5.2. Key Mergers & Acquisitions
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Face-care
6.3.2. Skincare
6.4. Market Attractiveness Analysis, by Product Type
7. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Skin Lightening or De-pigmenting
7.3.2. Rhytide Reduction
7.3.3. Anti-wrinkle/Aging
7.3.4. Scar-reducing
7.3.5. Others
7.4. Market Attractiveness Analysis, by Indication
8. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Physician Dispensed Cosmeceuticals Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2031
9.2.1. Face-care
9.2.2. Skincare
9.3. Market Value Forecast, by Indication, 2017–2031
9.3.1. Skin Lightening or De-pigmenting
9.3.2. Rhytide Reduction
9.3.3. Anti-wrinkle/Aging
9.3.4. Scar-reducing
9.3.5. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Indication
9.5.3. By Country
10. Europe Physician Dispensed Cosmeceuticals Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Face-care
10.2.2. Skincare
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Skin Lightening or De-pigmenting
10.3.2. Rhytide Reduction
10.3.3. Anti-wrinkle/Aging
10.3.4. Scar-reducing
10.3.5. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Indication
10.5.3. By Country/Sub-region
11. Asia Pacific Physician Dispensed Cosmeceuticals Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Face-care
11.2.2. Skincare
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Skin Lightening or De-pigmenting
11.3.2. Rhytide Reduction
11.3.3. Anti-wrinkle/Aging
11.3.4. Scar-reducing
11.3.5. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By Indication
11.5.3. By Country/Sub-region
12. Latin America Physician Dispensed Cosmeceuticals Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Face-care
12.2.2. Skincare
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Skin Lightening or De-pigmenting
12.3.2. Rhytide Reduction
12.3.3. Anti-wrinkle/Aging
12.3.4. Scar-reducing
12.3.5. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By Indication
12.5.3. By Country/Sub-region
13. Middle East & Africa Physician Dispensed Cosmeceuticals Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Face-care
13.2.2. Skincare
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Skin Lightening or De-pigmenting
13.3.2. Rhytide Reduction
13.3.3. Anti-wrinkle/Aging
13.3.4. Scar-reducing
13.3.5. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By Indication
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. AbbVie Inc. (Allergan)
14.2.1.1. Company Overview
14.2.1.2. Financial Overview
14.2.1.3. Product Portfolio
14.2.1.4. SWOT Analysis
14.2.1.5. Strategic Overview
14.2.2. L'Oreal S.A.
14.2.2.1. Company Overview
14.2.2.2. Financial Overview
14.2.2.3. Product Portfolio
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Jan Marini Skin Research, Inc.
14.2.3.1. Company Overview
14.2.3.2. Financial Overview
14.2.3.3. Product Portfolio
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Athena Cosmetics, Inc.
14.2.4.1. Company Overview
14.2.4.2. Financial Overview
14.2.4.3. Product Portfolio
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. ZO Skin Health Inc.
14.2.5.1. Company Overview
14.2.5.2. Financial Overview
14.2.5.3. Product Portfolio
14.2.5.4. SWOT Analysis
14.2.5.5. Strategic Overview
14.2.6. Galderma Laboratories, L.P.
14.2.6.1. Company Overview
14.2.6.2. Financial Overview
14.2.6.3. Product Portfolio
14.2.6.4. SWOT Analysis
14.2.6.5. Strategic Overview
14.2.7. Procter & Gamble Co.
14.2.7.1. Company Overview
14.2.7.2. Financial Overview
14.2.7.3. Product Portfolio
14.2.7.4. SWOT Analysis
14.2.7.5. Strategic Overview
14.2.8. The Estée Lauder Companies, Inc.
14.2.8.1. Company Overview
14.2.8.2. Financial Overview
14.2.8.3. Product Portfolio
14.2.8.4. SWOT Analysis
14.2.8.5. Strategic Overview
14.2.9. Merz Pharma
14.2.9.1. Company Overview
14.2.9.2. Financial Overview
14.2.9.3. Product Portfolio
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. Obagi Cosmeceuticals LLC
14.2.10.1. Company Overview
14.2.10.2. Financial Overview
14.2.10.3. Product Portfolio
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview
14.2.11. iS CLINICAL
14.2.11.1. Company Overview
14.2.11.2. Financial Overview
14.2.11.3. Product Portfolio
14.2.11.4. SWOT Analysis
14.2.11.5. Strategic Overview
14.2.12. Neutrogena
14.2.12.1. Company Overview
14.2.12.2. Financial Overview
14.2.12.3. Product Portfolio
14.2.12.4. SWOT Analysis
14.2.12.5. Strategic Overview
List of Tables
Table 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type 2017–2031
Table 02: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017‒2031
Table 03: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 04: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 05: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 06: North America Physician Dispensed Cosmeceuticals Market (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 08: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 09: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 10: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 11: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 12: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 13: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 14: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 16: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 17: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
Table 18: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, by Indication, 2017–2031
List of Figures
Figure 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Physician Dispensed Cosmeceuticals Market Value Share, by Product Type, 2020
Figure 03: Global Physician Dispensed Cosmeceuticals Market Value Share, by Indication, 2020
Figure 04: Global Physician Dispensed Cosmeceuticals Market Value Share, by Region, 2020
Figure 05: Global Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 06: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 07: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Face-care, 2017–2031
Figure 08: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skincare, 2017–2031
Figure 09: Global Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 10: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 11: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Skin Lightening or De-pigmenting, 2017–2031
Figure 12: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Rhytide Reduction, 2017–2031
Figure 13: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Anti-wrinkle/Aging, 2017–2031
Figure 14: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Scar-reducing, 2017–2031
Figure 15: Global Physician Dispensed Cosmeceuticals Market (US$ Mn), by Others, 2017–2031
Figure 16: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Region, 2020 and 2031
Figure 17: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Region, 2021–2031
Figure 18: North America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 19: North America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country, 2020 and 2031
Figure 20: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country, 2021–2031
Figure 21: North America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 22: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 23: North America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 24: North America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 25: Europe Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 26: Europe Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 27: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 28: Europe Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 29: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 30: Europe Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 31: Europe Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 32: Asia Pacific Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 33: Asia Pacific Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 34: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 35: Asia Pacific Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 36: Asia Pacific Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 37: Latin America Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 38: Latin America Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 39: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 40: Latin America Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 41: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 42: Latin America Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 43: Latin America Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Figure 44: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value (US$ Mn) Forecast, 2017–2031
Figure 45: Middle East & Africa Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-Region, 2020 and 2031
Figure 46: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 47: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Product Type, 2020 and 2031
Figure 48: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Product Type, 2021–2031
Figure 49: Middle East & Africa Physician Dispensed Cosmeceuticals Market, by Indication, 2020 and 2031
Figure 50: Middle East & Africa Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Indication, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Physician Dispensed Cosmeceuticals Market
